Concepts (166)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
| Gastrointestinal Microbiome | 6 | 2021 | 1961 | 1.27 | Why? |
| Metabolomics | 5 | 2017 | 921 | 1.19 | Why? |
| Biodiversity | 2 | 2017 | 546 | 1.06 | Why? |
| Self Report | 4 | 2021 | 3802 | 0.83 | Why? |
| Prodromal Symptoms | 1 | 2020 | 133 | 0.79 | Why? |
| Fruit | 1 | 2021 | 313 | 0.74 | Why? |
| Hippurates | 1 | 2017 | 9 | 0.73 | Why? |
| Diseases in Twins | 2 | 2020 | 86 | 0.72 | Why? |
| Glutamates | 1 | 2017 | 12 | 0.72 | Why? |
| Sulfotransferases | 1 | 2018 | 25 | 0.72 | Why? |
| Vegetables | 1 | 2021 | 340 | 0.72 | Why? |
| Mobile Applications | 5 | 2021 | 3032 | 0.71 | Why? |
| Cytochrome P-450 CYP3A | 1 | 2018 | 88 | 0.70 | Why? |
| Diet | 3 | 2021 | 2052 | 0.70 | Why? |
| Twin Studies as Topic | 1 | 2017 | 9 | 0.69 | Why? |
| Palmitic Acids | 1 | 2017 | 28 | 0.68 | Why? |
| Mendelian Randomization Analysis | 1 | 2018 | 317 | 0.58 | Why? |
| Bone Density | 1 | 2018 | 335 | 0.56 | Why? |
| Uric Acid | 1 | 2017 | 285 | 0.54 | Why? |
| Disease Notification | 1 | 2020 | 639 | 0.53 | Why? |
| Fatty Acids, Omega-3 | 1 | 2017 | 306 | 0.53 | Why? |
| Leukocytes | 1 | 2021 | 1046 | 0.52 | Why? |
| Lipid Metabolism | 1 | 2017 | 572 | 0.50 | Why? |
| Metabolome | 4 | 2018 | 624 | 0.49 | Why? |
| Osteoporosis | 1 | 2018 | 410 | 0.47 | Why? |
| Weight Gain | 1 | 2017 | 552 | 0.47 | Why? |
| Smell | 1 | 2020 | 1851 | 0.43 | Why? |
| Dyslipidemias | 1 | 2017 | 791 | 0.43 | Why? |
| Drug-Related Side Effects and Adverse Reactions | 1 | 2021 | 1261 | 0.43 | Why? |
| Atherosclerosis | 1 | 2018 | 768 | 0.40 | Why? |
| Genome-Wide Association Study | 6 | 2019 | 1648 | 0.38 | Why? |
| Smartphone | 1 | 2020 | 1840 | 0.37 | Why? |
| Oxidative Stress | 1 | 2017 | 2050 | 0.31 | Why? |
| Docosahexaenoic Acids | 2 | 2017 | 145 | 0.30 | Why? |
| Olfaction Disorders | 2 | 2020 | 3704 | 0.29 | Why? |
| Osteoarthritis, Knee | 2 | 2018 | 158 | 0.29 | Why? |
| Genomics | 1 | 2017 | 3118 | 0.28 | Why? |
| Body Mass Index | 1 | 2017 | 4306 | 0.27 | Why? |
| Ruminococcus | 1 | 2021 | 20 | 0.23 | Why? |
| Clostridium | 1 | 2021 | 33 | 0.23 | Why? |
| Clostridiales | 1 | 2021 | 24 | 0.23 | Why? |
| Rheumatic Diseases | 1 | 2017 | 2675 | 0.21 | Why? |
| Actinobacteria | 1 | 2021 | 87 | 0.21 | Why? |
| Polysaccharides | 2 | 2018 | 854 | 0.20 | Why? |
| Epoxide Hydrolases | 1 | 2018 | 21 | 0.19 | Why? |
| Oxylipins | 1 | 2018 | 29 | 0.19 | Why? |
| Computer Systems | 1 | 2020 | 255 | 0.19 | Why? |
| Fatty Acids, Omega-6 | 1 | 2017 | 43 | 0.18 | Why? |
| United Kingdom | 5 | 2021 | 18046 | 0.18 | Why? |
| Cytochrome P-450 CYP2A6 | 1 | 2016 | 4 | 0.17 | Why? |
| Cytochrome P-450 CYP1A2 | 1 | 2016 | 25 | 0.17 | Why? |
| Nutrigenomics | 1 | 2017 | 15 | 0.17 | Why? |
| RNA, Ribosomal, 16S | 1 | 2021 | 793 | 0.17 | Why? |
| Polymorphism, Single Nucleotide | 4 | 2018 | 3607 | 0.17 | Why? |
| Immunoglobulin G | 2 | 2018 | 21571 | 0.16 | Why? |
| Eicosapentaenoic Acid | 1 | 2017 | 106 | 0.16 | Why? |
| Dietetics | 1 | 2017 | 66 | 0.16 | Why? |
| Glycosylation | 2 | 2018 | 1255 | 0.16 | Why? |
| Basic Helix-Loop-Helix Transcription Factors | 1 | 2016 | 96 | 0.16 | Why? |
| Nutritional Sciences | 1 | 2017 | 57 | 0.16 | Why? |
| Caffeine | 1 | 2016 | 67 | 0.16 | Why? |
| Femoral Artery | 1 | 2018 | 213 | 0.15 | Why? |
| Diagnosis, Computer-Assisted | 1 | 2021 | 436 | 0.15 | Why? |
| Biomarkers | 5 | 2021 | 23361 | 0.15 | Why? |
| Fasting | 1 | 2021 | 555 | 0.15 | Why? |
| Vaccination | 1 | 2021 | 19050 | 0.15 | Why? |
| Confidence Intervals | 1 | 2018 | 744 | 0.15 | Why? |
| Hypertension | 1 | 2017 | 8895 | 0.15 | Why? |
| Receptors, Aryl Hydrocarbon | 1 | 2016 | 152 | 0.14 | Why? |
| Carotid Artery Diseases | 1 | 2018 | 251 | 0.14 | Why? |
| Middle Aged | 15 | 2021 | 270681 | 0.14 | Why? |
| Female | 18 | 2021 | 380317 | 0.13 | Why? |
| Societies, Scientific | 1 | 2017 | 414 | 0.13 | Why? |
| Plaque, Atherosclerotic | 1 | 2018 | 423 | 0.13 | Why? |
| Safety | 1 | 2021 | 1583 | 0.12 | Why? |
| Cardiovascular Diseases | 1 | 2018 | 11497 | 0.12 | Why? |
| Pneumonia, Viral | 5 | 2020 | 243684 | 0.12 | Why? |
| Nutrition Assessment | 1 | 2017 | 527 | 0.12 | Why? |
| Fatigue | 2 | 2020 | 2479 | 0.12 | Why? |
| Humans | 26 | 2021 | 930598 | 0.11 | Why? |
| Gene Regulatory Networks | 1 | 2017 | 820 | 0.11 | Why? |
| Male | 16 | 2021 | 367725 | 0.11 | Why? |
| Antigens, CD | 1 | 2016 | 984 | 0.11 | Why? |
| Immunoglobulins | 1 | 2016 | 811 | 0.11 | Why? |
| Leukocyte Count | 1 | 2021 | 3178 | 0.11 | Why? |
| Data Collection | 1 | 2020 | 1769 | 0.10 | Why? |
| Hot Temperature | 1 | 2017 | 1299 | 0.10 | Why? |
| Metabolic Syndrome | 1 | 2017 | 810 | 0.10 | Why? |
| Adult | 10 | 2021 | 244371 | 0.10 | Why? |
| Pain | 1 | 2017 | 1084 | 0.10 | Why? |
| Lymphocyte Count | 1 | 2021 | 4758 | 0.09 | Why? |
| Microbiota | 1 | 2019 | 1240 | 0.09 | Why? |
| Taste Disorders | 1 | 2020 | 1720 | 0.09 | Why? |
| Coronavirus Infections | 4 | 2020 | 253789 | 0.09 | Why? |
| Aged | 11 | 2021 | 215776 | 0.09 | Why? |
| Membrane Glycoproteins | 1 | 2016 | 2273 | 0.09 | Why? |
| Congresses as Topic | 1 | 2017 | 1347 | 0.08 | Why? |
| Dyspnea | 1 | 2020 | 3847 | 0.08 | Why? |
| International Cooperation | 1 | 2020 | 3436 | 0.08 | Why? |
| Gene Expression | 1 | 2017 | 3332 | 0.08 | Why? |
| Genetic Variation | 2 | 2019 | 3919 | 0.08 | Why? |
| Cough | 1 | 2020 | 4891 | 0.08 | Why? |
| Odds Ratio | 1 | 2018 | 5861 | 0.08 | Why? |
| Risk Factors | 6 | 2021 | 71621 | 0.08 | Why? |
| Genetic Predisposition to Disease | 2 | 2019 | 4027 | 0.07 | Why? |
| Disease Susceptibility | 1 | 2019 | 4002 | 0.07 | Why? |
| Blood Pressure | 1 | 2017 | 2198 | 0.07 | Why? |
| Arthritis, Rheumatoid | 1 | 2019 | 2043 | 0.07 | Why? |
| Hydroxymethylglutaryl-CoA Reductase Inhibitors | 1 | 2017 | 1510 | 0.07 | Why? |
| Alcohol Drinking | 1 | 2017 | 1663 | 0.07 | Why? |
| Antineoplastic Agents | 1 | 2020 | 3550 | 0.07 | Why? |
| Cohort Studies | 2 | 2018 | 36005 | 0.07 | Why? |
| Feces | 1 | 2017 | 4235 | 0.06 | Why? |
| Clinical Laboratory Techniques | 2 | 2020 | 23402 | 0.06 | Why? |
| Models, Biological | 1 | 2020 | 4907 | 0.06 | Why? |
| Interleukin-6 | 1 | 2021 | 7522 | 0.06 | Why? |
| Longitudinal Studies | 1 | 2017 | 9893 | 0.06 | Why? |
| Prevalence | 2 | 2020 | 25773 | 0.06 | Why? |
| Ultrasonography | 1 | 2018 | 4409 | 0.06 | Why? |
| Twins, Dizygotic | 1 | 2020 | 40 | 0.06 | Why? |
| Cell Line | 1 | 2017 | 12040 | 0.06 | Why? |
| Mass Screening | 1 | 2020 | 8005 | 0.05 | Why? |
| Twins, Monozygotic | 1 | 2020 | 83 | 0.05 | Why? |
| Contact Tracing | 1 | 2020 | 8448 | 0.05 | Why? |
| Prospective Studies | 2 | 2021 | 43301 | 0.05 | Why? |
| Pandemics | 4 | 2020 | 389249 | 0.05 | Why? |
| Theobromine | 1 | 2016 | 4 | 0.04 | Why? |
| Acetylglucosamine | 1 | 2017 | 14 | 0.04 | Why? |
| Pain Threshold | 1 | 2017 | 46 | 0.04 | Why? |
| Solubility | 1 | 2018 | 382 | 0.04 | Why? |
| Glycomics | 1 | 2017 | 61 | 0.04 | Why? |
| Theophylline | 1 | 2016 | 39 | 0.04 | Why? |
| Aged, 80 and over | 2 | 2017 | 88759 | 0.04 | Why? |
| Disease Transmission, Infectious | 1 | 2020 | 9044 | 0.04 | Why? |
| Prognosis | 1 | 2020 | 32490 | 0.04 | Why? |
| Biomedical Research | 1 | 2017 | 5270 | 0.04 | Why? |
| Coffee | 1 | 2016 | 79 | 0.04 | Why? |
| United States | 2 | 2020 | 46150 | 0.04 | Why? |
| Blood | 1 | 2017 | 274 | 0.04 | Why? |
| Exome | 1 | 2017 | 207 | 0.04 | Why? |
| Quantitative Trait Loci | 1 | 2017 | 340 | 0.04 | Why? |
| Risk Assessment | 1 | 2018 | 25439 | 0.03 | Why? |
| Betacoronavirus | 4 | 2020 | 204454 | 0.03 | Why? |
| Severity of Illness Index | 1 | 2020 | 48226 | 0.03 | Why? |
| Neoplasms | 1 | 2020 | 17251 | 0.03 | Why? |
| Autoimmunity | 1 | 2019 | 841 | 0.03 | Why? |
| Animals | 2 | 2019 | 78931 | 0.03 | Why? |
| Cross-Sectional Studies | 1 | 2017 | 53120 | 0.03 | Why? |
| Age Factors | 2 | 2021 | 21039 | 0.02 | Why? |
| Case-Control Studies | 2 | 2018 | 17671 | 0.02 | Why? |
| Diarrhea | 1 | 2020 | 2743 | 0.02 | Why? |
| Sulfonamides | 1 | 2017 | 1294 | 0.02 | Why? |
| Phenotype | 1 | 2017 | 4037 | 0.02 | Why? |
| Predictive Value of Tests | 1 | 2021 | 9537 | 0.02 | Why? |
| Double-Blind Method | 1 | 2017 | 5988 | 0.02 | Why? |
| Sex Factors | 1 | 2020 | 11014 | 0.02 | Why? |
| Models, Theoretical | 1 | 2020 | 6659 | 0.01 | Why? |
| Disease Management | 1 | 2019 | 6841 | 0.01 | Why? |
| Disease Progression | 1 | 2018 | 13580 | 0.01 | Why? |
| Retrospective Studies | 2 | 2021 | 105322 | 0.01 | Why? |
| Randomized Controlled Trials as Topic | 1 | 2017 | 10649 | 0.01 | Why? |
| Time Factors | 1 | 2021 | 31397 | 0.01 | Why? |
| Global Health | 1 | 2020 | 13911 | 0.01 | Why? |
| Surveys and Questionnaires | 1 | 2020 | 43792 | 0.01 | Why? |
| Tomography, X-Ray Computed | 1 | 2018 | 25144 | 0.01 | Why? |
| Young Adult | 1 | 2020 | 93724 | 0.01 | Why? |
Menni's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts
(166)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(157)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_